DEA Rejects D.C. Medical Dispensary's Registration Bid

A Washington, D.C.-area medical cannabis dispensary was expecting a federal registration. What arrived was an Order to Show Cause from the DEA, a document that was shared with MJBizDaily and is the basis for the reporting here.

Schedule III was supposed to open a door for state-licensed medical operators. The early results are lopsided. More than 900 dispensaries reportedly got registrations in the first batch, at least some operators have been turned away, and thousands of applicants are still waiting for an answer.

One caveat up front: the DEA has not said how many operators it has rejected, in which states, or why. Everything below rests on a leaked order, trade-press reporting and company statements, so read it as an early snapshot.

What the Order to Show Cause Says

The document at the center of this story is an Order to Show Cause, which the DEA sent to an unidentified medical dispensary in the Washington, D.C. area. MJBizDaily obtained it. An order like this is a procedural step that typically invites a response, so it is not necessarily the final word on the dispensary's status.

According to a partial excerpt, the DEA says it cannot work with the dispensary because D.C.'s program lets medical patients self-certify a medical ailment. That wording comes from an excerpt rather than the full text, so the exact phrasing should be checked against the order itself.

Plenty remains unknown. Here is what the reporting does not tell us:

• The dispensary's name
• The specific legal basis for the rejection
• The deadline to respond
• How many other operators have received similar orders
• Which states those operators are in, and the DEA's stated reasons

The DEA has not volunteered any of that. Until it does, a single order can show the agency's reasoning in one case but cannot show a pattern.

Where Registrations Stand Under Schedule III

Roughly 6,000 timely applications were reported from medical dispensaries and manufacturers, yet only about 900 dispensary registrations were issued on the first Friday, meaning the vast majority of applicants had not yet been approved.

The Justice Department issued an April final order reclassifying state-regulated medical cannabis as a Schedule 3 drug. The exact effective date and Federal Register citation still need to be verified against primary documents.

The DEA has published a list of timely applicants, and it shows more than 6,000 timely applications from medical dispensaries and manufacturers. That is the size of the queue. Cannabis Business Times reports the DEA issued more than 900 dispensary registrations on the first Friday, in the first seven states, all medical-only. The states are not named in the material available, and the date appears to be around Oct. 30-31, 2026, which is unconfirmed.

Trulieve Cannabis Corp. then said on a Monday, apparently Nov. 2, that the DEA had registered some of its medical dispensaries. Those registrations are the first major tangible benefit for medical operators since rescheduling, apart from expected federal tax relief.

Still, only a handful of operators have publicly announced that the DEA recognized their dispensaries, and thousands are waiting. The Timely Applicants list also shows how uneven the picture is by state. Alabama, for example, has four operating medical dispensaries and no pending dispensary applications.

Adult-Use States Look Like the Real Problem

The sharper worry is adult-use states. Minneapolis-based In-Dispensary, an adult-use retailer, said the DEA rejected its registration bid. Owner Mark Eide told the Minnesota Star Tribune the agency called it not in the public interest.

The Star Tribune also reported that the DEA may reject all Schedule III applicants from adult-use states. That is a newspaper report, not a DEA statement. The stakes in Minnesota are real: 30 businesses filed timely Schedule III applications, including 26 dispensaries. MJBizDaily adds that the DEA has rejected at least one operator serving both adult-use and medical customers.

The math explains the anxiety. The first seven states were all medical-only, which leaves 24 states with legal adult-use cannabis in question. Virginia is the exception, since it has legalized adult-use but has no licensed adult-use market yet.

D.C. complicates the tidy adult-use story, though. Its rejected dispensary sits in a medical program, and the cited problem is self-certification. If that reasoning holds, medical-only status will not be enough on its own, and program design could decide outcomes well beyond adult-use markets.

What Operators Should Watch Next

Cannabis Business Times says the DEA warned that businesses granted federal registration face rules that could disrupt state programs. The specifics were not in the material available, so operators should find the actual language before assuming what compliance will require.

The legal track is also unsettled. Related headlines point to a DEA judge halting the rescheduling process and possibly reopening the hearing record, though the current status needs verifying. Other headlines say a federal court denied anti-rescheduling parties' motion to stay the Schedule III order, and that the DEA is pushing the judge to wrap up the process. Those items were not read in full, so treat them as leads rather than settled facts.

At the state level, South Dakota's attorney general found that rescheduling will not affect the state program, a reminder that each state is reading this differently.

For operators, the practical steps are plain:

1. Read your state's program rules against the DEA's stated concerns, including how patients are certified.
2. Check the Timely Applicants list for your own status.
3. Talk to counsel before responding to any DEA notice.

Legality varies by state, and none of this is legal advice.

Registration is turning out to be a judgment on how each state program is built, not a rubber stamp that follows rescheduling. Self-certification and adult-use sales are the early flashpoints, and the D.C. order suggests the first one can sink a medical applicant.

Until the DEA publishes rejection numbers and its reasoning, operators are working from a leaked document, a handful of company announcements and press reports. Treat every early data point as provisional, including the ones in this article.

Browse our seed collection.